(Q45411636)

English

SARS-CoV spike protein-expressing recombinant vaccinia virus efficiently induces neutralizing antibodies in rabbits pre-immunized with vaccinia virus

scientific article published on 11 September 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

14 December 2017

SARS-CoV spike protein-expressing recombinant vaccinia virus efficiently induces neutralizing antibodies in rabbits pre-immunized with vaccinia virus (English)

1 reference

Europe PubMed Central

14 December 2017

0 references

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

object named as

vaccinia virus

1 reference

based on heuristic

inferred from title

author name string

Masahiro Kitabatake

1

1 reference

Europe PubMed Central

14 December 2017

Shingo Inoue

2

1 reference

Europe PubMed Central

14 December 2017

Fumihiko Yasui

3

1 reference

Europe PubMed Central

14 December 2017

Shoji Yokochi

4

1 reference

Europe PubMed Central

14 December 2017

Masaaki Arai

5

1 reference

Europe PubMed Central

14 December 2017

Kouichi Morita

6

1 reference

Europe PubMed Central

14 December 2017

Hisatoshi Shida

7

1 reference

Europe PubMed Central

14 December 2017

Minoru Kidokoro

8

1 reference

Europe PubMed Central

14 December 2017

Fukashi Murai

9

1 reference

Europe PubMed Central

14 December 2017

Mai Quynh Le

10

1 reference

Europe PubMed Central

14 December 2017

Kyosuke Mizuno

11

1 reference

Europe PubMed Central

14 December 2017

Kouji Matsushima

12

1 reference

Europe PubMed Central

14 December 2017

Michinori Kohara

13

1 reference

Europe PubMed Central

14 December 2017

language of work or name

0 references

publication date

11 September 2006

1 reference

Europe PubMed Central

14 December 2017

1 reference

Europe PubMed Central

14 December 2017

25

1 reference

Europe PubMed Central

14 December 2017

4

1 reference

Europe PubMed Central

14 December 2017

630-637

1 reference

Europe PubMed Central

14 December 2017

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.039

7 January 2021

A novel coronavirus associated with severe acute respiratory syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.039

7 January 2021

Coronavirus as a possible cause of severe acute respiratory syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.039

7 January 2021

Coronavirus spike proteins in viral entry and pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.039

7 January 2021

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.039

7 January 2021

Coronaviruses: structure and genome expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.039

7 January 2021

Neutralizing antibodies in patients with severe acute respiratory syndrome-associated coronavirus infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.039

7 January 2021

T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus spike protein elicit a specific T-cell immune response in patients who recover from SARS.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.039

7 January 2021

SARS in China. Tracking the roots of a killer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.039

7 January 2021

Bats are natural reservoirs of SARS-like coronaviruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.039

7 January 2021

Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.039

7 January 2021

Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.039

7 January 2021

Inactivated SARS-CoV vaccine prepared from whole virus induces a high level of neutralizing antibodies in BALB/c mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.039

7 January 2021

A subcutaneously injected UV-inactivated SARS coronavirus vaccine elicits systemic humoral immunity in mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.039

7 January 2021

A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.039

7 January 2021

Generation and characterization of DNA vaccines targeting the nucleocapsid protein of severe acute respiratory syndrome coronavirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.039

7 January 2021

Effects of a SARS-associated coronavirus vaccine in monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.039

7 January 2021

Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.039

7 January 2021

Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.039

7 January 2021

Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.039

7 January 2021

Gene structures of low-neurovirulent vaccinia virus LC16m0, LC16m8, and their Lister original (LO) strains

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.039

7 January 2021

Constructions of vaccinia virus A-type inclusion body protein, tandemly repeated mutant 7.5 kDa protein, and hemagglutinin gene promoters support high levels of expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.039

7 January 2021

Development and evaluation of a novel loop-mediated isothermal amplification method for rapid detection of severe acute respiratory syndrome coronavirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.039

7 January 2021

Amino acids 1055 to 1192 in the S2 region of severe acute respiratory syndrome coronavirus S protein induce neutralizing antibodies: implications for the development of vaccines and antiviral agents

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.039

7 January 2021

Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.039

7 January 2021

Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.039

7 January 2021

Evaluation of modified vaccinia virus Ankara based recombinant SARS vaccine in ferrets

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.039

7 January 2021

Duration of antiviral immunity after smallpox vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.039

7 January 2021

Monoclonal antibodies to the spike protein of feline infectious peritonitis virus mediate antibody-dependent enhancement of infection of feline macrophages

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.039

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased expression in vivo and in vitro of foreign genes directed by A-type inclusion body hybrid promoters in recombinant vaccinia viruses

1 reference

https://pubmed.ncbi.nlm.nih.gov/17011679

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of the recombinant vaccinia viruses that express HTLV-I envelope gene on HTLV-I infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/17011679

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.VACCINE.2006.08.039

1 reference

Europe PubMed Central

14 December 2017

0 references

1 reference

Europe PubMed Central

14 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45411636&oldid=2076841558"